The prostaglandin D(2) receptor 2 pathway in asthma: a key player in airway inflammation

Por Domingo, Christian, Palomares, Oscar, Sandham, David A., Erpenbeck, Veit J., Altman, Pablo
Publicado no Respir Res (2018)

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Vol...

Por Erpenbeck, Veit J., Vets, Eva, Gheyle, Lien, Osuntokun, Wande, Larbig, Michael, Neelakantham, Srikanth, Sandham, David, Dubois, Gerald, Elbast, Walid, Goldsmith, Paul, Weiss, Markus
Publicado no Clin Pharmacol Drug Dev (2016)

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP(2) Receptor Antagonist for Treatment of Asthma

Por Sandham, David A., Barker, Lucy, Brown, Lyndon, Brown, Zarin, Budd, David, Charlton, Steven J., Chatterjee, Devnandan, Cox, Brian, Dubois, Gerald, Duggan, Nicholas, Hall, Edward, Hatto, Julia, Maas, Janet, Manini, Jodie, Profit, Rachael, Riddy, Darren, Ritchie, Catherine, Sohal, Bindi, Shaw, Duncan, Stringer, Rowan, Sykes, David A., Thomas, Matthew, Turner, Katharine L., Watson, Simon J., West, Ryan, Willard, Elisabeth, Williams, Gareth, Willis, Jennifer
Publicado no ACS Med Chem Lett (2017)

Correction to “Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP(2) Receptor Antagonist for Treatment of Asthma”

Por Sandham, David A., Barker, Lucy, Brown, Lyndon, Brown, Zarin, Budd, David, Charlton, Steven J., Chatterjee, Devnandan, Cox, Brian, Dubois, Gerald, Duggan, Nicholas, Hall, Edward, Hatto, Julia, Leblanc, Catherine, Maas, Janet, Manini, Jodie, Profit, Rachael, Riddy, Darren, Ritchie, Catherine, Sohal, Bindi, Shaw, Duncan, Stringer, Rowan, Sykes, David A., Thomas, Matthew, Turner, Katharine L., Watson, Simon J., West, Ryan, Willard, Elisabeth, Williams, Gareth, Willis, Jennifer
Publicado no ACS Med Chem Lett (2017)